363 related articles for article (PubMed ID: 23949703)
1. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.
Suberviola B; Castellanos-Ortega A; Ruiz Ruiz A; Lopez-Hoyos M; Santibañez M
Intensive Care Med; 2013 Nov; 39(11):1945-52. PubMed ID: 23949703
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of lipopolysaccharide binding protein and procalcitonin in patients with severe sepsis and septic shock admitted to intensive care].
García de Guadiana-Romualdo LM; Rebollo-Acebes S; Esteban-Torrella P; Jiménez-Sánchez R; Hernando-Holgado A; Ortín-Freire A; Viqueira-González M; Trujillo-Santos J; Jiménez Santos E; Pedregosa Díaz J; Albaladejo-Otón MD; Allegue-Gallego JM
Med Intensiva; 2015 May; 39(4):207-12. PubMed ID: 24953001
[TBL] [Abstract][Full Text] [Related]
4. Serum soluble triggering receptor expressed on myeloid cells-1 and procalcitonin can reflect sepsis severity and predict prognosis: a prospective cohort study.
Li Z; Wang H; Liu J; Chen B; Li G
Mediators Inflamm; 2014; 2014():641039. PubMed ID: 24672147
[TBL] [Abstract][Full Text] [Related]
5. The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial.
Elke G; Bloos F; Wilson DC; Brunkhorst FM; Briegel J; Reinhart K; Loeffler M; Kluge S; Nierhaus A; Jaschinski U; Moerer O; Weyland A; Meybohm P;
Crit Care; 2018 Mar; 22(1):79. PubMed ID: 29562917
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.
Enguix-Armada A; Escobar-Conesa R; García-De La Torre A; De La Torre-Prados MV
Clin Chem Lab Med; 2016 Jan; 54(1):163-8. PubMed ID: 26083268
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.
Gonzalez Del Castillo J; Wilson DC; Clemente-Callejo C; Román F; Bardés-Robles I; Jiménez I; Orviz E; Dastis-Arias M; Espinosa B; Tornero-Romero F; Giol-Amich J; González V; Llopis-Roca F;
Crit Care; 2019 Oct; 23(1):335. PubMed ID: 31665092
[TBL] [Abstract][Full Text] [Related]
8. Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score.
Travaglino F; De Berardinis B; Magrini L; Bongiovanni C; Candelli M; Silveri NG; Legramante J; Galante A; Salerno G; Cardelli P; Di Somma S
BMC Infect Dis; 2012 Aug; 12():184. PubMed ID: 22874067
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.
Bernal-Morell E; García-Villalba E; Vera MDC; Medina B; Martinez M; Callejo V; Valero S; Cinesi C; Piñera P; Alcaraz A; Marin I; Muñoz A; Cano A
J Infect; 2018 Mar; 76(3):249-257. PubMed ID: 29246637
[TBL] [Abstract][Full Text] [Related]
10. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
[TBL] [Abstract][Full Text] [Related]
11. MR- proADM to detect specific types of organ failure in infection.
Andrés C; Andaluz-Ojeda D; Cicuendez R; Nogales L; Martín S; Martin-Fernandez M; Almansa R; Calvo D; Esteban-Velasco MC; Vaquero-Roncero LM; Ríos-Llorente A; Sanchez-Barrado E; Muñoz-Bellvís L; Aldecoa C; Bermejo-Martin JF
Eur J Clin Invest; 2020 Jun; 50(6):e13246. PubMed ID: 32307701
[TBL] [Abstract][Full Text] [Related]
12. [Ventilator bundle treatment of acute respiratory distress syndrome and its correlation with biomarkers of inflammation].
Yang J; Dong C; Li J; Zhang H; Zhang H; Song R; Yang Z; Feng F; Qi Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Aug; 26(8):544-8. PubMed ID: 25124901
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.
Suberviola B; Castellanos-Ortega A; Llorca J; Ortiz F; Iglesias D; Prieto B
Swiss Med Wkly; 2012; 142():w13542. PubMed ID: 22430899
[TBL] [Abstract][Full Text] [Related]
14. [The value of pro-adrenomedullin in early diagnosis of sepsis].
Yan L; Cailan L; Hong L; Zheng L; Wei D
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Sep; 27(9):739-42. PubMed ID: 26955700
[TBL] [Abstract][Full Text] [Related]
15. suPAR as a prognostic biomarker in sepsis.
Donadello K; Scolletta S; Covajes C; Vincent JL
BMC Med; 2012 Jan; 10():2. PubMed ID: 22221662
[TBL] [Abstract][Full Text] [Related]
16. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.
Koch A; Voigt S; Kruschinski C; Sanson E; Dückers H; Horn A; Yagmur E; Zimmermann H; Trautwein C; Tacke F
Crit Care; 2011; 15(1):R63. PubMed ID: 21324198
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of procalcitonin and mid-regional pro-adrenomedullin in septic paediatric patients.
Solé-Ribalta A; Bobillo-Pérez S; Valls A; Girona-Alarcón M; Launes C; Cambra FJ; Jordan I; Esteban E
Eur J Pediatr; 2020 Jul; 179(7):1089-1096. PubMed ID: 31974673
[TBL] [Abstract][Full Text] [Related]
18. [The study on pro-adrenomedullin as a new biomarker in sepsis prognosis and risk stratification].
Kang FX; Wang RL; Yu KL; Wei Q
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Aug; 20(8):452-5. PubMed ID: 18687169
[TBL] [Abstract][Full Text] [Related]
19. [The correlation between procalcitonin, C-reactive protein and severity scores in patients with sepsis and their value in assessment of prognosis].
Wang S; Chen D
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):97-101. PubMed ID: 25665606
[TBL] [Abstract][Full Text] [Related]
20. Pro-adrenomedullin, pro-endothelin-1, procalcitonin, C-reactive protein and mortality risk in critically ill children: a prospective study.
Rey C; García-Hernández I; Concha A; Martínez-Camblor P; Botrán M; Medina A; Prieto B; López-Herce J
Crit Care; 2013 Oct; 17(5):R240. PubMed ID: 24131732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
